WO2004012655A3 - Anti-microbial compositions and methods of using same - Google Patents

Anti-microbial compositions and methods of using same Download PDF

Info

Publication number
WO2004012655A3
WO2004012655A3 PCT/US2003/023125 US0323125W WO2004012655A3 WO 2004012655 A3 WO2004012655 A3 WO 2004012655A3 US 0323125 W US0323125 W US 0323125W WO 2004012655 A3 WO2004012655 A3 WO 2004012655A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
microbe
exposure
same
microbial
Prior art date
Application number
PCT/US2003/023125
Other languages
French (fr)
Other versions
WO2004012655A2 (en
Inventor
Richard A Rosenbloom
Original Assignee
The Quigley Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/024794 external-priority patent/WO2003013428A2/en
Priority claimed from US10/359,889 external-priority patent/US7396546B2/en
Priority to CA002495447A priority Critical patent/CA2495447A1/en
Priority to NZ537821A priority patent/NZ537821A/en
Priority to JP2004526143A priority patent/JP2005534699A/en
Priority to AU2003256736A priority patent/AU2003256736B2/en
Application filed by The Quigley Corp filed Critical The Quigley Corp
Priority to EP03766897A priority patent/EP1545470A4/en
Priority to MXPA05001051A priority patent/MXPA05001051A/en
Publication of WO2004012655A2 publication Critical patent/WO2004012655A2/en
Publication of WO2004012655A3 publication Critical patent/WO2004012655A3/en
Priority to IL16660805A priority patent/IL166608A0/en
Priority to HK05112150.6A priority patent/HK1082660A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

An anti-microbial composition is provided. The anti-microbial composition includes a first ingredient obtainable from ginger, a second ingredient obtainable from green tea, an optional third ingredient available from turmeric, and, optionally, an acceptable carrier. Also provided are methods of reducing, treating or preventing at least one symptom or adverse effect of microbial infection in a patient. The methods include the step of administering to the patient prior to expected exposure to a microbe, concurrently with exposure to a microbe, or after exposure to a microbe, an effective amount of a composition of the invention.
PCT/US2003/023125 2002-08-06 2003-07-24 Anti-microbial compositions and methods of using same WO2004012655A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MXPA05001051A MXPA05001051A (en) 2002-08-06 2003-07-24 Anti-microbial compositions and methods of using same.
EP03766897A EP1545470A4 (en) 2002-08-06 2003-07-24 Anti-microbial compositions and methods of using same
NZ537821A NZ537821A (en) 2002-08-06 2003-07-24 Anti-viral compositions useful for treating one or more adverse effects of viral infections
JP2004526143A JP2005534699A (en) 2002-08-06 2003-07-24 Antibacterial composition and method of using the same
AU2003256736A AU2003256736B2 (en) 2002-08-06 2003-07-24 Anti-microbial compositions and methods of using same
CA002495447A CA2495447A1 (en) 2002-08-06 2003-07-24 Anti-microbial compositions and methods of using same
IL16660805A IL166608A0 (en) 2002-08-06 2005-01-31 Anti-microbial compositions and methods of using same
HK05112150.6A HK1082660A1 (en) 2002-08-06 2005-12-29 Anti-microbial compositions and methods of using same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2002/024794 WO2003013428A2 (en) 2001-08-06 2002-08-06 Nutritional supplements and methods of using same
USPCT/US02/24794 2002-08-06
US10/359,889 2003-02-06
US10/359,889 US7396546B2 (en) 2001-08-06 2003-02-06 Anti-microbial compositions and methods of using same

Publications (2)

Publication Number Publication Date
WO2004012655A2 WO2004012655A2 (en) 2004-02-12
WO2004012655A3 true WO2004012655A3 (en) 2004-09-16

Family

ID=34549101

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/023125 WO2004012655A2 (en) 2002-08-06 2003-07-24 Anti-microbial compositions and methods of using same

Country Status (10)

Country Link
EP (1) EP1545470A4 (en)
JP (1) JP2005534699A (en)
CN (1) CN1674875A (en)
AU (1) AU2003256736B2 (en)
CA (1) CA2495447A1 (en)
HK (1) HK1082660A1 (en)
IL (1) IL166608A0 (en)
MX (1) MXPA05001051A (en)
NZ (1) NZ537821A (en)
WO (1) WO2004012655A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
US8652533B2 (en) * 2004-07-07 2014-02-18 Mitsui Norin Co., Ltd. Durable biocides and disinfectants
JP4788994B2 (en) * 2005-01-26 2011-10-05 独立行政法人農業・食品産業技術総合研究機構 Functional food and drink
JP5032003B2 (en) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 Analgesic and anti-inflammatory lozenges for oral mucosa
FR2887749B1 (en) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim FOOD SUPPLEMENT AND ITS USE FOR THE PREVENTION OR CONTROL OF THE EFFECTS OF JOINT DISEASES
FR2887748B1 (en) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim FOOD SUPPLEMENT AND ITS USE FOR THE PREVENTION OR CONTROL OF THE EFFECTS OF JOINT DISEASES.
EP1928268A1 (en) * 2005-09-30 2008-06-11 DSMIP Assets B.V. Novel compositions containing polyphenols
AU2007225549B2 (en) * 2006-03-10 2012-09-27 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
JP5207341B2 (en) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 Inflammatory cytokine production inhibitor
MX2009006396A (en) * 2006-12-14 2009-06-26 The Quigley Corp Compositions and methods for treating infectious bronchitis.
US20100247685A1 (en) * 2006-12-14 2010-09-30 The Quigley Corporation Methods For Treating and Reducing the Incidence of Newcastle Disease
KR101077920B1 (en) 2009-07-08 2011-10-31 한국생명공학연구원 Composition for prevention and treatment of influenza virus and composition for inhibiting the activity of neuraminidase comprising extracts of Turmeric
KR101121615B1 (en) 2009-09-14 2012-02-28 주식회사 바이오에프디엔씨 Antibacterial Detergent Composition
KR100962334B1 (en) * 2009-10-19 2010-06-10 주식회사 중앙백신연구소 Antiviral agents with inhibitory activities on avian and swine influenza virus or novel influenza virus by compounds isolated from curcurma longa
ES2553766T3 (en) 2009-10-22 2015-12-11 Maresins Pharma, Inc. Herbicidal compositions comprising ginger and solidarity for the treatment of influenza infection
ITMI20111259A1 (en) * 2011-07-06 2013-01-07 Eye Tech Srl QUICK-RELEASE ORO-SOLUBLE COMPOSITION CONTAINING CURCUMINE DERIVATIVES
JP2013100253A (en) * 2011-11-09 2013-05-23 Shigeru Abe Anticandidal activity composition including ginger component
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
EP3103465A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
JP2019011279A (en) * 2017-06-30 2019-01-24 小林製薬株式会社 Diarrhea inhibitor
CN117338758B (en) * 2023-12-06 2024-03-12 北京远大九和药业有限公司 Pharmaceutical composition and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060012A (en) * 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 A kind of preparation method of chewing gum
CN1072823A (en) * 1992-06-13 1993-06-09 文士开 The compound method of fruit zymic tea
CN1116068A (en) * 1994-01-25 1996-02-07 刘俊松 Preparing method the main agent of natural emulsified nectar
JP2000157209A (en) * 1998-11-27 2000-06-13 Kagetoshi Kawauchi Sprinkling healthy food
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6032705A (en) * 1983-08-02 1985-02-19 Shiraimatsu Shinyaku Kk Antimicrobial agent
JPH02276562A (en) * 1989-04-19 1990-11-13 Mitsui Norin Kk Antimicrobial agent
JPH0319670A (en) * 1989-06-17 1991-01-28 Chieko Shiroi Cereal mixed with ukon (curcuma) and its processed food product
JP2540719B2 (en) * 1993-10-21 1996-10-09 有限会社ビオールケミカル Tea leaves
JPH10130161A (en) * 1996-09-06 1998-05-19 Otsuka Pharmaceut Co Ltd Composition against helicobacter pylori
JPH10279432A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JPH11302121A (en) * 1998-04-16 1999-11-02 Fuudeiamu Tokunaga:Kk Antimicrobial agent using green tea catechin
JP2000212094A (en) * 1998-11-18 2000-08-02 Takeda Chem Ind Ltd Pharmaceutical preparation for oral cavity
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060012A (en) * 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 A kind of preparation method of chewing gum
CN1072823A (en) * 1992-06-13 1993-06-09 文士开 The compound method of fruit zymic tea
CN1116068A (en) * 1994-01-25 1996-02-07 刘俊松 Preparing method the main agent of natural emulsified nectar
JP2000157209A (en) * 1998-11-27 2000-06-13 Kagetoshi Kawauchi Sprinkling healthy food
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same

Also Published As

Publication number Publication date
EP1545470A2 (en) 2005-06-29
CA2495447A1 (en) 2004-02-12
WO2004012655A2 (en) 2004-02-12
MXPA05001051A (en) 2005-04-08
AU2003256736B2 (en) 2009-09-10
HK1082660A1 (en) 2006-06-16
CN1674875A (en) 2005-09-28
IL166608A0 (en) 2006-01-15
EP1545470A4 (en) 2009-07-01
JP2005534699A (en) 2005-11-17
AU2003256736A1 (en) 2004-02-23
NZ537821A (en) 2007-05-31

Similar Documents

Publication Publication Date Title
WO2004012655A3 (en) Anti-microbial compositions and methods of using same
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
WO2007038506A3 (en) Method for the treatment of cachexia
WO2005095403A3 (en) Macrocyclic compounds as inhibitors of viral replication
MY143795A (en) Tetrahydropyridoindole derivatives
WO2005063232A8 (en) Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
WO2005074913A3 (en) Compositions and methods for treating contracture
WO2005067546A3 (en) Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
WO2007047146A3 (en) Inhibitors of viral replication
WO2005105107A3 (en) Hormone treatment of multiple sclerosis
EP2305698A3 (en) Macrocyclic inhibitors of Hepatitis C virus replication
WO2006078277A3 (en) Dalbavancin compositions for treatment of bacterial infections
EP1774968A4 (en) Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food
UA91677C2 (en) Macrocyclic compounds as inhibitors of hcv replication
DK1501499T3 (en) Transepicutaneous form of administration for the treatment of restless legs syndrome
WO2006034001A3 (en) Methods of treating hiv infection
HK1121936A1 (en) Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
WO2007030944A3 (en) Methods of cardioprotection using dichloroacetate in combination with an inotrope
WO2007100758A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
EP1637132A4 (en) External preparation for athlete´s foot treatment
WO2003066597A3 (en) Guanidino compounds
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
WO2007075750A3 (en) Compositions containing cotinus coggygria extract and use thereof in treating wounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005/00517

Country of ref document: ZA

Ref document number: 200500517

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 537821

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 258/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/001051

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 166608

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2003256736

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2495447

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020057002080

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 20038189666

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2004526143

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003766897

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020057002080

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003766897

Country of ref document: EP